Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion

Abstract

Background:Transarterial chemo-embolisation (TACE) is recommended for patients with BCLC intermediate stage hepatocellular carcinoma (stage B), particularly in patients with good underlying liver function and minimal symptoms. The hepatoma arterial embolisation prognostic (HAP) score combines measures of liver function and tumour-related factors to offer a… (More)
DOI: 10.1038/bjc.2017.211

Topics

Cite this paper

@inproceedings{Waked2017TransarterialCO, title={Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion}, author={I Waked and Sarah Berhane and Hidenori Toyoda and Stephen L. Chan and Nicholas H. Stern and Daniel Palmer and Toshifumi Tada and Winnie Yeo and Frankie Mo and Dominik Bettinger and Martha M Kirstein and Mercedes I{\~n}arrairaegui and Asmaa Ibrahim Gomaa and A. Vogel and Tim Meyer and Bruno Sangro and Paul Bs Lai and Takashi Kumada and P J Johnson}, booktitle={British Journal of Cancer}, year={2017} }